SINGAPORE, Aug. 29, 2026 /PRNewswire/ — Gauth, the AI-powered study companion, recently redefines its role in education, moving beyond simple problem-solving to become a comprehensive learning partner. While many tools provide answers, Gauth focuses on ensuring students truly understand the “how” and “why” behind every concept.

Visualizing Knowledge for Deep Comprehension

Powered by its proprietary Gauth AI education model, the platform transforms abstract concepts into visible, understandable content. Unlike standard solvers, Gauth utilizes visual aids like graphs, highlights, and tables to break down complex problems. Students simply snap a photo to access unlimited, step-by-step explanations without needing complex prompts. This approach turns passive answer-checking into an active learning process, helping students visualize the logic behind every solution.

A Complete Learning Loop: From Practice to Mastery

Gauth supports the entire academic journey, from initial problem-solving to review and consolidation. The app automatically organizes key concepts and mistakes into customized Flashcards, enabling efficient review. To reinforce learning, it generates targeted Quizzes based on individual weak points, ensuring students master difficult topics before moving forward. This closed-loop system ensures that every interaction contributes to long-term retention and academic growth.

Comprehensive Support Across All Subjects

Gauth now covers a complete range of academic disciplines and grade levels, extending from STEM fields to humanities. The platform offers deep adaptation to Vietnam’s local curriculum, ensuring relevance for regional learners. Students can access support for daily study tasks and comprehensive assessment preparation sessions, all aligned with specific educational requirements. This localized approach ensures that every learner receives guidance that matches their classroom lessons and national assessment preparation needs.

Real-Time Guidance with Live Tutor

For moments requiring deeper intervention, Gauth’s Live Tutor feature offers real-time voice interaction. Mimicking a physical classroom, tutors use interactive whiteboards to provide step-by-step walkthroughs, knowledge supplements, and live Q&A sessions. This human-AI hybrid model ensures that students receive not just the correct answer, but the guidance needed to overcome specific learning barriers.

Download Gauth: [App Store Link] | [Google Play Link]

Follow Gauth on social media: [YouTube] | [X] | [TikTok]

About Gauth

Gauth is your AI study companion, dedicated to providing easy access to quality education. Through advanced artificial intelligence and a commitment to academic excellence, Gauth empowers students worldwide to understand concepts deeply, solve problems confidently, and achieve their academic potential. Gauth it, Ace it!

Media Contact: support@gauth.com

Business Demonstrates Strong Resilience,

Profitability Continues to Materialise

Results Highlights

• Tycoon Group sustained its turnaround success from the previous year, recording a net profit of approximately HK$6.3 million during the Period (1H2025: net loss of approximately HK$7.7 million), representing a year-on-year increase of 182.6% and successfully turning loss into profit compared to the Last Period.
• During the Period, the Group recorded revenue of approximately HK$496.1 million, representing a slight decrease of 2.7% compared to HK$510.1 million for 1H2025.
• Facing severe challenges such as rising operational costs, shifts in the spending patterns of both local consumers and Individual Visit Scheme travellers, and the appreciation of the Hong Kong dollar, the Group’s overall revenue decreased only slightly, demonstrating the strong resilience of the Group’s business in adversity. The Group will continue to closely monitor market conditions, flexibly adjust strategies according to consumer preferences, and optimise its product mix, striving to increase revenue. Concurrently, the Group will adopt stringent cost control measures; coupled with the traditional peak consumption season in the second half of the year, revenue in the second half of 2026 is expected to improve, continuing on its profitable track.
• Leveraging its extensive practical experience in the Southeast Asian market, the Group seized opportunities to adjust its market strategies, proactively optimising its product mix, strategically reducing the proportion of products with relatively low gross profit margins, and actively exploring and introducing high-quality products with relatively higher gross profit margins. Although the Group’s overall distribution sales in the Southeast Asian market recorded a decrease during the Period, the Group’s businesses in Singapore and Malaysia both recorded improvements in gross profit margins following the product structure adjustment. This strategic portfolio restructuring is believed to bring higher-quality, more stable, and more sustainable revenue streams to the Group.
• The Board has resolved not to declare any interim dividend for 1H2026 (1H2025: Nil).

HONG KONG, Aug. 29, 2026 /PRNewswire/ — Tycoon Group Holdings Limited (“Tycoon Group“; Stock Code: 3390), a reputable Hong Kong-based omnichannel marketing and management service integrator of healthcare and wellbeing-related products, announces the unaudited condensed consolidated interim results of the Group for the six months ended 30 June 2026 (“Period” or “1H2026”).

Sustaining Last Year’s Turnaround Success, Returning to a Profitable Track
Following the full-year turnaround from loss to profit in 2025, the Group recorded a net profit of approximately HK$6.3 million for its 2026 interim results (1H2025: net loss of approximately HK$7.7 million), representing a year-on-year increase of 182.6% and sustaining the profitable momentum from the previous year. During the Period, the Group recorded a slight decrease in revenue of 2.7% to approximately HK$496.1 million (1H2025: HK$510.1 million). Facing severe challenges such as rising operational costs and shifts in the spending patterns of both local consumers and Individual Visit Scheme travellers, the Group’s overall revenue decreased only slightly, demonstrating the strong resilience of the Group’s business in adversity. The Group will continue to closely monitor market conditions, flexibly adjust strategies according to consumer preferences, and optimise its product mix, striving to increase revenue. Concurrently, the Group will adopt stringent cost control measures; coupled with the traditional peak consumption season in the second half of the year, revenue in the second half of 2026 is expected to improve, continuing on its profitable track.

In the first half of 2026, in Hong Kong, due to weakened consumer purchasing desire, Hong Kong distribution sales amounted to HK$238.8 million, representing a year-on-year decrease of 7.2% (1H2025: HK$257.4 million); Macau distribution sales were HK$43.7 million, representing a year-on-year increase of 1.8% (1H2025: HK$42.9 million). During the Period, due to the Group’s adjustment of its Southeast Asian market strategy, proactive optimisation of its product mix, strategic reduction in the proportion of products with relatively low gross profit margins, and active addition of higher-margin products, total distribution sales in the Southeast Asian market recorded HK$23.6 million, representing a year-on-year decrease of 45.2% (1H2025: HK$43.1 million). In particular, Singapore distribution sales recorded HK$17.8 million, down by 51.4% year-on-year, whilst Malaysia amounted to HK$5.7 million, representing a decrease of 9.4%. The Group expects to progressively expand into more Southeast Asian countries in the future, with the higher gross profit margin sales of the Southeast Asian distribution business expected to achieve healthier growth.

Leveraging Practical Overseas Expansion Experience in Southeast Asia to Strategically Restructure Product Mix and Increase High-Margin Products, Paving the Way for New Milestones
Notably, the Group’s development in the Southeast Asian market continued to progress. As one of the few in the industry to take the lead in expanding overseas and establishing local roots, the Group possesses extensive practical experience in local markets and seized the opportunity to adjust market strategies. Although the Group’s overall distribution sales in the Southeast Asian market recorded a decrease during the Period, this was due to the Group’s proactive optimisation of its product mix, strategically reducing the proportion of products with relatively low gross profit margins, and actively exploring and introducing high-quality products with relatively higher gross profit margins. In particular, the Group’s businesses in Singapore and Malaysia both recorded improvements in gross profit margins during the Period following the product structure adjustment, affirming the prudence of the Group’s strategic expansion into Southeast Asia in recent years.

Omnichannel Brand Marketing and Management Services for Brands
Meanwhile, the Group acts as the distributor for numerous overseas brands, including the exclusive agency for Kuku Bima Ener-G!, the flagship energy drink powder product of Sido Muncul, a leading Indonesian herbal pharmaceutical brand, in the food and beverage channel in Malaysia; the exclusive agency for Unichi, popular bear-shaped hair growth gummies, in Hong Kong; the exclusive agency for Japanese hair loss prevention and care brand Kaminowa in Hong Kong, Macau, and Singapore; and the exclusive agency for Helaslim, a popular Japanese slimming and beauty brand, in Singapore. The Group has also secured exclusive distribution rights for PNKids, a leading children’s multivitamin brand in Singapore, covering Singapore and Malaysia; distribution rights for plu, a popular Korean body care brand, in Hong Kong, Macau, Singapore, and Malaysia; and the Group has been appointed as the general distributor for the well-known Mainland brand Dong-E-E-Jiao (東阿阿膠) in Hong Kong.

The Group maintains a long-term partnership with JBM (Healthcare) Limited (“JBM” (HKEX Stock Code: 2161), together with its subsidiaries, the “JBM Group“). The Group represents numerous time-honoured brands under the JBM Group that are renowned in Hong Kong, Mainland China, and Southeast Asia, including the century-old Li Chung Shing Tong Po Chai Pills (李眾勝堂保濟丸), Ho Chai Kung (何濟公), Flying Eagle Medicated Oil (飛鷹活絡油) from Europharm, and products under Tin Hee Tong (天喜堂), including its flagship product Tin Hee Tong Tin Hee Pills (天喜堂天喜丸), which enjoys strong brand recognition in Hong Kong and Mainland China. Notably, the Group has been granted the exclusive agency rights in Singapore and Cambodia for Li Chung Shing Tong Po Chai Pills, and the exclusive agency rights in Singapore for Europharm Singapore products.

Strengthening R&D of High-Gross-Margin Self-Owned and Collaborative Brand Products
In addition to its agency brand business, the Group continues to actively expand its self-owned brand products. Popular brands include Boost & Guard Pro (BG Pro 博健專研) and Craft by Wakan (和漢匠心). Collaborative brands include Kinmen Qiangxiao (金門強效), SEASONS (田心日辰), and MiTime. To date, the Group has registered over 60 self-owned brand product trademarks. Best-selling products include Craft by Wakan Japanese Probiotics (和漢匠心日本多元益生菌), BG Pro Dr. Growth Calcium (BG Pro博健專研長高鈣), and BG Pro Ultra Purity Deep Sea Fish Oil (BG PRO 博健專研頂級深海魚油), while collaborative brand products include Kinmen Qiangxiao I-Tiao-Gung Plaster (金門強效一條根精油貼布), SEASONS NMN 40000 (田心日辰逆轉齡 NMN 40000), and MiTime Kids DHA 60 Softgels (MiTime兒童魚油藻油DHA).

The Group closely monitors market demands and continuously upgrades and improves (i) its popular self-owned brand products, including Craft by Wakan Japan Liver Boost EX (和漢匠心日本護肝盾EX), Craft by Wakan Japan Joint Active (和漢匠心日本活關腱), and BG Pro CoQ-10 (BG Pro 博健專研醫學級輔酶Q10); and (ii) collaborative brand products, including Kinmen Qiangxiao I-Tiao-Gung Pain Relief Penetrating Liquid (金門強效一條根滲透鎮痛露) and Kinmen Qiangxiao I-Tiao-Gung Pain Relief Roller Cream (金門強效一條根滾珠鎮痛膏). The Group is also actively collaborating with two major local personal care product chain stores to launch new products tailored to local consumer needs and establish a comprehensive sales channel network.

Regarding collaborative brands, to complement the Group’s strategy of strengthening own brand development, Mr. Wong Ka Chun Michael, the Group’s Chairman, Executive Director and Chief Executive Officer, acquired in his personal capacity the century-old Hong Kong brand Po Wo Tong and collaborates with the Group to launch and sell more new products, injecting new vitality into this time-honoured brand with over a century of history. The Group has also invited renowned actress Ms. Selena Lee (李施嬅小姐) as spokesperson for the flagship best-selling products Po Wo Tong Dampness Removing Pills (寶和堂祛濕丸) and Po Wo Tong Dampness Removing Bath Capsule (寶和堂祛濕浸泡珠). Meanwhile, during the last financial year, the Group established the pop-up “Po Wo Tong Wellness Concept Store” at Harbour City shopping mall in Tsim Sha Tsui, which is popular among Mainland tourists and local consumers, allowing more young people and travellers to become acquainted with Po Wo Tong.

Mr. Wong Ka Chun Michael, Chairman and Chief Executive Officer of Tycoon Group, said, “The Group has successfully maintained the positive turnaround momentum from FY2025, with profitability continuing to materialise, affirming that the Group’s operational strategies are well-directed and that our business demonstrates strong resilience. In the first half of this year, leveraging extensive practical experience in the Southeast Asian market, management decisively optimised and upgraded the local product portfolio, strategically reducing the proportion of products with relatively low gross profit margins and focusing resources on more high-margin, premium products. Although this forward-looking strategy moderately affected overall distribution sales in Southeast Asia in the short term, the Group firmly believes that following a brief transition period, it will generate higher-quality, more stable, and more sustainable revenue streams. With the steady expansion of our Southeast Asian operations, coupled with the brand collaborations, product R&D, and cost-reduction and efficiency-enhancement initiatives actively pursued in recent years, the Group’s core profitability is fully on track, and we look forward to continuing to create greater value and higher profitability.”

About Tycoon Group Holdings Limited (Stock Code: 3390)
Tycoon Group is a reputable omnichannel marketing and management service integrator of healthcare and wellbeing-related products in Hong Kong. The Group specialises in providing one-stop omnichannel services for proprietary Chinese medicines (“PCM”), health supplements, skincare, personal care and other healthcare products, including brand agent, promotion and marketing, management, distribution and sales. Through years of dedicated efforts, the Group supplies to nearly 100,000 online and offline sales points across Hong Kong, Macau, the PRC and Southeast Asia, selling products from over 300 local and overseas brands and offering more than 2,000 products, with the mission of bringing health and vitality to consumers in Mainland China, Hong Kong, Macau and Asia-Pacific. The Group actively develops self-owned brands, including “Boost & Guard Pro”, ” Craft by Wakan”, and collaborative brands such as “Kinmen Qiangxiao”. The Group also collaborates with Po Wo Tong, a century-old Hong Kong brand, to launch and sell more popular products. The Group is one of the major distributors for PCM in Hong Kong and has established sound relationships with the top two personal care product chain retailers in Hong Kong. For more details, please visit the Group’s official website: https://www.tycoongroup.com.hk/

ZIBO, China, Aug. 29, 2026 /PRNewswire/ — INTCO Medical (“the Company”, 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders rose 17.86% to RMB 837.3 million (approx. US$124.6 million). Adjusted net profit attributable to shareholders, excluding nonrecurring gains and losses, climbed 165.00% to RMB 1.06 billion (approx. US$157.7 million).

By the end of the reporting period, INTCO Medical’s annualized production capacity for disposable gloves had reached 107 billion pieces. The total comprised 74 billion disposable nitrile gloves and 33 billion disposable vinyl gloves. This scale reinforces the Company’s position as the world’s largest producer of disposable gloves.

INTCO Medical’s integrated value chain extends from nitrile latex and the research, development and manufacturing of core production equipment to glove production and global sales. Through nitrile latex manufacturers in which it holds controlling or equity interests, the Company strengthens raw material supply security, helping mitigate the impact of international crude oil price fluctuations on key raw material costs while enhancing supply stability and cost efficiency. Its coordinated domestic and international production capacity enables the Company to allocate manufacturing resources according to market demand, respond efficiently to customer needs and support reliable delivery across global markets. Together, these capabilities strengthen operational resilience.

During the reporting period, R&D expenses rose 20.62% to RMB 245.9 million (approx. US$36.6 million). The Company continued to develop high-performance products, including Syntex™ Synthetic Latex Gloves, a proprietary glove that does not contain natural latex proteins and offers high elasticity and puncture resistance, and Synmax Pro Exam Gloves, an enhanced vinyl glove for food service and industrial applications. The Company has also introduced safety work gloves, household gloves and other products to meet diverse application needs.

Smart manufacturing boosts efficiency and quality. INTCO Medical’s latest nitrile glove production line spans more than 1.6 kilometers and incorporates about 500 control points. Its precision distributed control system automatically manages temperature and liquid levels based on production conditions, helping reduce labor and energy consumption while maintaining stable output. The Company’s glove product yield remained above 99% during the reporting period.

INTCO Medical will continue optimizing global capacity and advancing protective product innovation to support growth.

SINGAPORE, Aug. 29, 2026 /PRNewswire/ — Noah Holdings Limited (the “Company” or “Noah”) (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese high-net-worth investors, today announced changes to its board of directors (the “Board”) and the composition of its Board committees.

Noah has appointed Ms. Tianjing Zhang as an independent director (a non-executive director for purposes of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Hong Kong Listing Rules”), effective August 29, 2026. Ms. Cynthia Jinhong Meng will retire as an independent director upon the expiration of the independent director agreement entered into between her and the Company at the end of August 28, 2026, after three years of service. Ms. Meng’s departure did not result from any disagreement with the Company and the Board expresses its sincere gratitude for her invaluable contribution during her tenure.

Mr. David Zhang has served as our independent director since June 2024 under applicable U.S. regulations, and, for purposes of the Hong Kong Listing Rules, a non-executive director. The Corporate Governance and Nominating Committee conducted a comprehensive assessment of the independence of Mr. David Zhang under Rule 3.13 of the Hong Kong Listing Rules, including the circumstances contemplated under Rules 3.13(3) and 3.13(7). In particular, they considered, among other matters, that the two-year cooling-off period contemplated under Rule 3.13(3) had expired before Mr. Zhang provided his confirmation of independence and that more than two and a half years had elapsed since he retired from Kirkland & Ellis in January 2024. They also considered that Mr. Zhang has not held any executive or management position within the Company or its subsidiaries and that his involvement has been limited to Board-level and Audit Committee oversight. After considering all relevant facts and circumstances and Mr. Zhang’s confirmation of independence, the Board and the Corporate Governance and Nominating Committee are satisfied that he is independent for purposes of Rule 3.13 of the Hong Kong Listing Rules and he has been re-designated as an independent Director under the Hong Kong Listing Rules, with effect from August 29, 2026. The Board is confident that Mr. Zhang’s expertise in cross-border securities offerings, U.S. and Hong Kong capital markets and dual-listed company governance will strengthen the Board’s independent oversight and committee functions.

In connection with Ms. Meng’s retirement and the appointment and/or re-designation described above, the Board has resolved to change the composition of its committees with effect from August 29, 2026. The Audit Committee shall comprise Ms. Xiangrong Li as Chairperson, Mr. David Zhang and Ms. Tianjing Zhang as members. The Compensation Committee shall comprise Ms. May Yihong Wu as Chairperson, Mr. Boquan He and Ms. Xiangrong Li as members. The Corporate Governance and Nominating Committee shall comprise Ms. Jingbo Wang as Chairperson, Ms. May Yihong Wu and Mr. David Zhang as members.

Ms. Tianjing Zhang has nearly two decades of experience in cross-border disputes, regulatory investigations, crisis management, compliance and international legal risk management. She has served as head of international business of HOZU Capital since May 2025, where she focuses on assessing and underwriting international arbitration and litigation matters and makes investment recommendations. From January 2012 to April 2025, Ms. Zhang practiced at Kirkland & Ellis International LLP and served as managing partner and chief representative of its Shanghai office before her resignation. During her tenure, she led the firm’s China cross-border dispute resolution and government, regulatory and investigations practice, representing global clients in complex multi-jurisdictional litigation and government-led and internal investigations. Before joining Kirkland & Ellis International LLP, she practiced at Holland & Knight LLP in San Francisco from April 2008 to December 2011, and appeared before U.S. federal and state courts.

Ms. Zhang holds a Juris Doctor degree from The University of Texas School of Law, a Master of Arts degree in political science (international relations) from Georgetown University and a Bachelor of Laws degree in international law from China Foreign Affairs University. She is admitted to practice law in the State of California, U.S. Ms. Zhang was named “Leading Lawyer of the Year” at The Legal 500 China Awards 2023 and has also been recognized by The Legal 500 Asia Pacific, Chambers and Partners and Benchmark Litigation Asia-Pacific.

Ms. Jingbo Wang, co-founder and chairwoman of Noah, commented, “I would like to express my sincere gratitude to Ms. Meng for her contributions to Noah where her dedication and guidance was instrumental in strengthening our governance framework. I wish her all the best in her future endeavors. I’d also like to extend a warm welcome to Ms. Tianjing Zhang where I am confident her extensive legal and regulatory experience will prove invaluable in shaping our future strategic direction. I am also pleased that Mr. David Zhang has been re-designated as an independent director under the Hong Kong Listing Rules, reflecting the Board’s confidence in his independence and expertise. These changes strengthen the Board’s legal, regulatory, capital markets and corporate governance expertise, broaden its diversity of perspectives and reinforce our commitment to the highest standards of corporate governance.”

ABOUT NOAH HOLDINGS LIMITED

Noah Holdings Limited (NYSE: NOAH and HKEX: 6686) is a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese high-net-worth investors. Noah’s American depositary shares, or ADSs, are listed on the New York Stock Exchange under the symbol “NOAH,” and its shares are listed on the Main Board of the Hong Kong Stock Exchange under the stock code “6686.” One ADS represents five ordinary shares, par value $0.00005 per share. 

In the first half of 2026, Noah distributed RMB40.4 billion (US$6.0 billion) of investment products. Through Gopher Asset Management and Olive Asset Management, Noah had assets under management of RMB140.9 billion (US$20.8 billion) as of June 30, 2026.

Founded in 2005, the firm pioneered a business model combining wealth management and asset management and has continued to build its international platform over the years. As of June 30, 2026, Noah had 469,987 registered clients. The Company reports its operations under six business segments — Mainland China public securities (Noah Upright), Mainland China asset management (Gopher Asset Management), Mainland China insurance (Glory), International wealth management (ARK Wealth Management), International asset management (Olive Asset Management), and International insurance and comprehensive services (Glory Family Heritage) — plus headquarters. As of June 30, 2026, Noah had established branches and service capabilities across mainland China, Hong Kong, Singapore, Japan, and key U.S. markets, including New York, Los Angeles, and Silicon Valley, reflecting its international operating footprint. 

For more information, please visit Noah’s investor relations website at ir.noahgroup.com.

SAFE HARBOR STATEMENT

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Noah may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in announcements, circulars or other publications made on the website of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Noah’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These statements include, but are not limited to, estimates regarding the sufficiency of Noah’s cash and cash equivalents and liquidity risk. A number of factors could cause Noah’s actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: its goals and strategies; its future business development, financial condition and results of operations; the expected growth of the wealth management and asset management market in China and internationally; its expectations regarding demand for and market acceptance of the products it distributes; investment risks associated with investment products distributed to Noah’s investors, including the risk of default by counterparties or loss of value due to market or business conditions or misconduct by counterparties; its expectations regarding keeping and strengthening its relationships with key clients; relevant government policies and regulations relating to its industries; its ability to attract and retain qualified employees; its ability to stay abreast of market trends and technological advances; its plans to invest in research and development to enhance its product choices and service offerings; competition in its industries in China and internationally; general economic and business conditions in China; and its ability to effectively protect its intellectual property rights and not to infringe on the intellectual property rights of others. Further information regarding these and other risks is included in Noah’s filings with the U.S. Securities and Exchange Commission and the Hong Kong Stock Exchange. All information provided in this press release and in the attachments is as of the date of this press release, and Noah does not undertake any obligation to update any such information, including forward-looking statements, as a result of new information, future events or otherwise, except as required under the applicable law.